PURPOSE: To evaluate the safety of percutaneous dilatational tracheostomy (PDT) in critically ill patients on an extracorporeal lung assist device requiring therapeutic anticoagulation. METHODS: This was a retrospective, observational study on all patients undergoing tracheostomy while on pumpless extracorporeal lung assist or extracorporeal membrane oxygenation in intensive care units of two university hospitals in Germany between 2007 and 2013. RESULTS: During the study period PDT was performed on 118 patients. The median platelet count, international normalized ratio, and activated partial thromboplastin time before tracheostomy were 126 × 10(9)/L (range 16-617 × 10(9)/L), 1.1 (0.9-2.0) and 49 s (28-117 s), respectively. Seventeen patients (14.4%) received a maximum of three bags of pooled platelets, and eight patients (6.8%) received a maximum of four units of fresh frozen plasma before the procedure. In all patients the administration of intravenous heparin was briefly paused periprocedurally. No periprocedural clotting complication within the extracorporeal circuit was observed. Two patients (1.7%) suffered from procedure-related major bleeding, with one patient requiring conversion to a surgical tracheostomy. Two pneumothoraces (1.7%) were related to the PDT. One patient (0.8%) had analgosedation-related hypotension with brief and successful cardiopulmonary resuscitation. Minor bleeding from the tracheostomy site occurred in 37 cases (31.4%). No fatality was attributable to tracheostomy. CONCLUSIONS: The complication rates of PDT in the patients on extracorporeal lung support were low and comparable to those of other critically ill patients. Based on these results, we conclude that PDT performed by experienced operators with careful optimization of the coagulation state is a relatively safe procedure and not contraindicated for this patient group.
PURPOSE: To evaluate the safety of percutaneous dilatational tracheostomy (PDT) in critically illpatients on an extracorporeal lung assist device requiring therapeutic anticoagulation. METHODS: This was a retrospective, observational study on all patients undergoing tracheostomy while on pumpless extracorporeal lung assist or extracorporeal membrane oxygenation in intensive care units of two university hospitals in Germany between 2007 and 2013. RESULTS: During the study period PDT was performed on 118 patients. The median platelet count, international normalized ratio, and activated partial thromboplastin time before tracheostomy were 126 × 10(9)/L (range 16-617 × 10(9)/L), 1.1 (0.9-2.0) and 49 s (28-117 s), respectively. Seventeen patients (14.4%) received a maximum of three bags of pooled platelets, and eight patients (6.8%) received a maximum of four units of fresh frozen plasma before the procedure. In all patients the administration of intravenous heparin was briefly paused periprocedurally. No periprocedural clotting complication within the extracorporeal circuit was observed. Two patients (1.7%) suffered from procedure-related major bleeding, with one patient requiring conversion to a surgical tracheostomy. Two pneumothoraces (1.7%) were related to the PDT. One patient (0.8%) had analgosedation-related hypotension with brief and successful cardiopulmonary resuscitation. Minor bleeding from the tracheostomy site occurred in 37 cases (31.4%). No fatality was attributable to tracheostomy. CONCLUSIONS: The complication rates of PDT in the patients on extracorporeal lung support were low and comparable to those of other critically illpatients. Based on these results, we conclude that PDT performed by experienced operators with careful optimization of the coagulation state is a relatively safe procedure and not contraindicated for this patient group.
Authors: Vinciya Pandian; Ravi S Vaswani; Marek A Mirski; Elliott Haut; Shivam Gupta; Nasir I Bhatti Journal: Ear Nose Throat J Date: 2010-08 Impact factor: 1.697
Authors: L Cabrini; P C Bergonzi; D Mamo; E Dedola; S Colombo; S Morero; M Mucci; G Torri Journal: Minerva Anestesiol Date: 2008-05-13 Impact factor: 3.051
Authors: M Vargas; G Servillo; E Arditi; I Brunetti; L Pecunia; D Salami; C Putensen; M Antonelli; P Pelosi Journal: Minerva Anestesiol Date: 2012-11-22 Impact factor: 3.051
Authors: Igor D Gregoric; Matthew T Harting; Roman Kosir; Vijay S Patel; Jus Ksela; Gregory N Messner; Saverio La Francesca; O H Frazier Journal: J Heart Lung Transplant Date: 2005-10 Impact factor: 10.247
Authors: Ismael A Salas De Armas; Kha Dinh; Bindu Akkanti; Pushan Jani; Reshma Hussain; Lisa Janowiak; Kayla Kutilek; Manish K Patel; Mehmet H Akay; Rahat Hussain; Jayeshkumar Patel; Chandni Patel; Yafen Liang; John Zaki; Biswajit Kar; Igor D Gregoric Journal: J Extra Corpor Technol Date: 2020-12
Authors: Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit Journal: Intensive Care Med Date: 2014-01-24 Impact factor: 17.440
Authors: Laura Pasin; Elena Frati; Luca Cabrini; Giovanni Landoni; Pasquale Nardelli; Tiziana Bove; Maria Grazia Calabro; Anna Mara Scandroglio; Federico Pappalardo; Alberto Zangrillo Journal: Ann Card Anaesth Date: 2015 Jul-Sep
Authors: Ayan Sen; Hannelisa E Callisen; Cory M Alwardt; Joel S Larson; Amelia A Lowell; Stacy L Libricz; Pritee Tarwade; Bhavesh M Patel; Harish Ramakrishna Journal: Ann Card Anaesth Date: 2016 Jan-Mar